Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael R Jacobs

Showing results (61-70 of 258) with videos related to

Pageof 26
Sort By:
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|February 19, 2019
Effects of Roflumilast on Rehospitalization and Mortality in PatientsGerard J Criner, Michael R Jacobs, Huaqing Zhao, et al.
Microorganisms|February 24, 2024
Bacterial Contamination of Platelet ProductsMichael R Jacobs, Bowen Zhou, Aditi Tayal, et al.
Transfusion|February 17, 2007
Development of proficiency testing for detection of bacterial contamination of platelet productsSamantha Easley, Roslyn A Yomtovian, Patricia Sullivan, et al.
Optometry and Vision Science : Official Publication of the American Academy of Optometry|September 30, 2009
Risk factors for contact lens bacterial contamination during continuous wearLoretta B Szczotka-Flynn, Saralee Bajaksouzian, Michael R Jacobs, et al.
Antimicrobial Agents and Chemotherapy|April 18, 2002
Effects of amino acid alterations in penicillin-binding proteins (PBPs) 1a, 2b, and 2x on PBP affinities of penicillin, ampicillin, amoxicillin, cefditoren, cefuroxime, cefprozil, and cefaclor in 18 clinical isolates of penicillin-susceptible, -intermediate, and -resistant pneumococciKensuke Nagai, Todd A Davies, Michael R Jacobs, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|February 19, 2019
Effect of Lung Volume Reduction Surgery on Respiratory Muscle Strength in Advanced EmphysemaRachel N Criner, Daohai Yu, Michael R Jacobs, et al.
Clinical Therapeutics|March 15, 2003
Activity of nine oral agents against gram-positive and gram-negative bacteria encountered in community-acquired infections: use of pharmacokinetic/pharmacodynamic breakpoints in the comparative assessment of beta-lactam and macrolide antimicrobial agentsMihaela Peric, Frederick A Browne, Michael R Jacobs, et al.
International Journal of Antimicrobial Agents|October 19, 2002
Outcome of treatment of respiratory tract infections due to Streptococcus pneumoniae, including drug-resistant strains, with pharmacokinetically enhanced amoxycillin/clavulanateThomas M File, Michael R Jacobs, Michael D Poole, et al.
Antimicrobial Agents and Chemotherapy|February 27, 2003
Antianaerobe activity of RBX 7644 (ranbezolid), a new oxazolidinone, compared with those of eight other agentsLois M Ednie, Ashok Rattan, Michael R Jacobs, et al.
The Journal of Infectious Diseases|January 28, 2004
Four antibiotic-resistant Streptococcus pneumoniae clones unrelated to the pneumococcal conjugate vaccine serotypes, including 2 new serotypes, causing acute otitis media in southern IsraelNurith Porat, Galia Barkai, Michael R Jacobs, et al.
Pageof 26

Showing results (61-70 of 258) with videos related to

Sort By:
Pageof 26
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|February 19, 2019
Effects of Roflumilast on Rehospitalization and Mortality in PatientsGerard J Criner, Michael R Jacobs, Huaqing Zhao, et al.
Microorganisms|February 24, 2024
Bacterial Contamination of Platelet ProductsMichael R Jacobs, Bowen Zhou, Aditi Tayal, et al.
Transfusion|February 17, 2007
Development of proficiency testing for detection of bacterial contamination of platelet productsSamantha Easley, Roslyn A Yomtovian, Patricia Sullivan, et al.
Optometry and Vision Science : Official Publication of the American Academy of Optometry|September 30, 2009
Risk factors for contact lens bacterial contamination during continuous wearLoretta B Szczotka-Flynn, Saralee Bajaksouzian, Michael R Jacobs, et al.
Antimicrobial Agents and Chemotherapy|April 18, 2002
Effects of amino acid alterations in penicillin-binding proteins (PBPs) 1a, 2b, and 2x on PBP affinities of penicillin, ampicillin, amoxicillin, cefditoren, cefuroxime, cefprozil, and cefaclor in 18 clinical isolates of penicillin-susceptible, -intermediate, and -resistant pneumococciKensuke Nagai, Todd A Davies, Michael R Jacobs, et al.
Chronic Obstructive Pulmonary Diseases (Miami, Fla.)|February 19, 2019
Effect of Lung Volume Reduction Surgery on Respiratory Muscle Strength in Advanced EmphysemaRachel N Criner, Daohai Yu, Michael R Jacobs, et al.
Clinical Therapeutics|March 15, 2003
Activity of nine oral agents against gram-positive and gram-negative bacteria encountered in community-acquired infections: use of pharmacokinetic/pharmacodynamic breakpoints in the comparative assessment of beta-lactam and macrolide antimicrobial agentsMihaela Peric, Frederick A Browne, Michael R Jacobs, et al.
International Journal of Antimicrobial Agents|October 19, 2002
Outcome of treatment of respiratory tract infections due to Streptococcus pneumoniae, including drug-resistant strains, with pharmacokinetically enhanced amoxycillin/clavulanateThomas M File, Michael R Jacobs, Michael D Poole, et al.
Antimicrobial Agents and Chemotherapy|February 27, 2003
Antianaerobe activity of RBX 7644 (ranbezolid), a new oxazolidinone, compared with those of eight other agentsLois M Ednie, Ashok Rattan, Michael R Jacobs, et al.
The Journal of Infectious Diseases|January 28, 2004
Four antibiotic-resistant Streptococcus pneumoniae clones unrelated to the pneumococcal conjugate vaccine serotypes, including 2 new serotypes, causing acute otitis media in southern IsraelNurith Porat, Galia Barkai, Michael R Jacobs, et al.
Pageof 26